FRESENIUS MEDICAL CARE-ADR (FMS) Stock Income Statement
NYSE:FMS - New York Stock Exchange, Inc. - US3580291066 - ADR - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 19.49B | 19.34B | 19.45B | 19.40B | 17.62B | |||
| Minority Interest Expense | -193.99M | -202.96M | -233.46M | -220.92M | -249.72M | |||
| Cost Of Goods | 14.73B | 14.58B | 14.53B | 14.50B | 12.85B | |||
| Gross Profit | 4.77B | 4.76B | 4.93B | 4.89B | 4.77B | |||
| Operating Expenses | 3.44B | 3.49B | 3.65B | 3.61B | 2.99B | |||
| Research and Development | 179.17M | 183.49M | 231.97M | 228.62M | 220.78M | |||
| Selling, General, and Administrative Expenses | 3.12B | 3.14B | 3.20B | 3.17B | 2.77B | |||
| Operating Income | 1.33B | 1.27B | 1.28B | 1.29B | 1.78B | |||
| Interest Income/Expense | -195.73M | -223.65M | -250.14M | -262.74M | -198.15M | |||
| Non Recurring Items | 14.70M | 14.66M | 4.84M | 195.38M | -8.63M | |||
| Income Before Taxes | 1.15B | 1.06B | 1.03B | 1.22B | 1.57B | |||
| Income Tax | 337.59M | 316.06M | 300.56M | 324.95M | 352.83M | |||
| Net Income | 618.17M | 537.91M | 499.00M | 673.40M | 969.31M | |||
| EBITDA | 2.95B | 3.01B | 3.03B | 3.13B | 3.40B | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 1.05 | 0.92 | 0.85 | 1.15 | 1.65 | |||
| Non GAAP EPS | 1.63 | 1.63 | 1.28 | 1.55 | 1.73 | |||
| Statistics | ||||||||
| Gross Profit Margin | 24.46% | 24.60% | 25.32% | 25.23% | 27.09% | |||
| Profit Margin | 3.17% | 2.78% | 2.57% | 3.47% | 5.50% | |||
| Operating Profit Margin | 6.83% | 6.55% | 6.57% | 6.63% | 10.10% | |||
All data in EUR